rs794728261
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM1PP2
The NM_000138.5(FBN1):c.6959A>T(p.Asp2320Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000684 in 1,461,800 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D2320G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.6959A>T | p.Asp2320Val | missense_variant | 57/66 | ENST00000316623.10 | |
FBN1 | NM_001406716.1 | c.6959A>T | p.Asp2320Val | missense_variant | 56/65 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.6959A>T | p.Asp2320Val | missense_variant | 57/66 | 1 | NM_000138.5 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461800Hom.: 0 Cov.: 35 AF XY: 0.00000688 AC XY: 5AN XY: 727190
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2013 | p.Asp2320Val (GAT>GTT): c.6959 A>T in exon 57 of the FBN1 gene (NM_000138.4)The Asp2320Val variant in the FBN1 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Asp2320Val results in a non-conservative amino acid substitution of negatively charged Aspartic Acid with a non-polar Valine at a position that is class-conserved across species. Furthermore, the Asp2320Val variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Mutations in nearby residues (Cys2316Arg, Cys2318Arg, Cys2318Tyr) have been reported in association with Marfan syndrome, supporting the functional importance of this region of the protein. Nevertheless, in silico algorithms are not consistent in their predictions, but at least two concur that Asp2320Val is benign to the protein structure/function. With the clinical and molecular information available at this time, we cannot definitively determine if Asp2320Val is a disease-causing mutation or a rare benign variant. The variant is found in TAAD panel(s). - |
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 02, 2022 | ClinVar contains an entry for this variant (Variation ID: 200099). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FBN1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 2320 of the FBN1 protein (p.Asp2320Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at